VR Adviser, LLC - LYRA THERAPEUTICS INC ownership

LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 62 filers reported holding LYRA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.

Quarter-by-quarter ownership
VR Adviser, LLC ownership history of LYRA THERAPEUTICS INC
ValueSharesWeighting
Q1 2024$16,023,298
+18.7%
2,576,093
+0.0%
0.76%
-17.7%
Q4 2023$13,496,107
+273.5%
2,575,593
+178.7%
0.93%
+143.7%
Q3 2023$3,613,505
-4.9%
924,1700.0%0.38%
-37.4%
Q2 2023$3,798,339
+104.5%
924,1700.0%0.61%
+67.2%
Q1 2023$1,857,582
-36.0%
924,1700.0%0.36%
-25.8%
Q4 2022$2,901,894
-37.3%
924,1700.0%0.49%
-31.5%
Q3 2022$4,630,000
-11.3%
924,1700.0%0.71%
-30.5%
Q2 2022$5,222,000924,1701.03%
Other shareholders
LYRA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Perceptive Advisors 3,222,560$12,955,0000.26%
Ikarian Capital, LLC 422,338$1,698,0000.22%
PURA VIDA INVESTMENTS, LLC 520,544$2,093,0000.07%
Clearline Capital LP 119,924$482,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 66,900$269,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 38,516$155,0000.00%
Pentwater Capital Management LP 60,000$241,0000.00%
Worth Asset Management, LLC 650$3,0000.00%
Close Asset Management Ltd 7,000$30,0000.00%
OSAIC HOLDINGS, INC. 500$2,0000.00%
View complete list of LYRA THERAPEUTICS INC shareholders